BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 33575936)

  • 1. Pheochromocytoma/paraganglioma crisis: case series from a tertiary referral center for pheochromocytomas and paragangliomas.
    Meijs AC; Snel M; Corssmit EPM
    Hormones (Athens); 2021 Jun; 20(2):395-403. PubMed ID: 33575936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phaeochromocytoma and paraganglioma].
    Cornu E; Belmihoub I; Burnichon N; Grataloup C; Zinzindohoué F; Baron S; Billaud E; Azizi M; Gimenez-Roqueplo AP; Amar L
    Rev Med Interne; 2019 Nov; 40(11):733-741. PubMed ID: 31493938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Pheochromocytoma/Paraganglioma syndrome: an overview on mechanisms, diagnosis and management.
    Lima JV; Kater CE
    Int Braz J Urol; 2023; 49(3):307-319. PubMed ID: 37115176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis and Management of Pheochromocytomas and Paragangliomas: A Guide for the Clinician.
    Sharma S; Fishbein L
    Endocr Pract; 2023 Dec; 29(12):999-1006. PubMed ID: 37586639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pheochromocytomas and Paragangliomas.
    Tevosian SG; Ghayee HK
    Endocrinol Metab Clin North Am; 2019 Dec; 48(4):727-750. PubMed ID: 31655773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management.
    Hamidi O
    Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):146-154. PubMed ID: 30893083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-6 producing pheochromocytoma/paraganglioma: case series from a tertiary referral centre for pheochromocytomas and paragangliomas.
    Meijs AC; Schroijen MA; Snel M; Corssmit EPM
    J Endocrinol Invest; 2021 Oct; 44(10):2253-2259. PubMed ID: 33715142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Metabolome Profiling for the Diagnosis of Catecholamine Producing Tumors.
    März J; Kurlbaum M; Roche-Lancaster O; Deutschbein T; Peitzsch M; Prehn C; Weismann D; Robledo M; Adamski J; Fassnacht M; Kunz M; Kroiss M
    Front Endocrinol (Lausanne); 2021; 12():722656. PubMed ID: 34557163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MANAGEMENT OF CATECHOLAMINE-SECRETING TUMORS IN PREGNANCY: A REVIEW.
    Prete A; Paragliola RM; Salvatori R; Corsello SM
    Endocr Pract; 2016 Mar; 22(3):357-70. PubMed ID: 26536138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pheochromocytoma and paraganglioma in childhood: a report of 2 cases report].
    Mosquera Gorostidi A; Justo Ranera A; Zakirian Denis SE; González Temprano N; Sagaseta de Ilúrdoz Uranga M; Molina Garicano J
    An Pediatr (Barc); 2015 Jan; 82(1):e175-80. PubMed ID: 25082130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging molecular markers of metastatic pheochromocytomas and paragangliomas.
    Goncalves J; Lussey-Lepoutre C; Favier J; Gimenez-Roqueplo AP; Castro-Vega LJ
    Ann Endocrinol (Paris); 2019 Jun; 80(3):159-162. PubMed ID: 31053249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pheochromocytoma and paraganglioma-an update on diagnosis, evaluation, and management.
    Jain A; Baracco R; Kapur G
    Pediatr Nephrol; 2020 Apr; 35(4):581-594. PubMed ID: 30603807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidisciplinary practice guidelines for the diagnosis, genetic counseling and treatment of pheochromocytomas and paragangliomas.
    Garcia-Carbonero R; Matute Teresa F; Mercader-Cidoncha E; Mitjavila-Casanovas M; Robledo M; Tena I; Alvarez-Escola C; Arístegui M; Bella-Cueto MR; Ferrer-Albiach C; Hanzu FA
    Clin Transl Oncol; 2021 Oct; 23(10):1995-2019. PubMed ID: 33959901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pheochromocytoma and paraganglioma: basics for the general practitioner].
    Loosli N; Köhler BB; Pechère-Bertschi A; Karenovics W; Triponex F
    Rev Med Suisse; 2014 Sep; 10(441):1650-2, 1654-5. PubMed ID: 25322623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease monitoring of patients with pheochromocytoma or paraganglioma by biomarkers and imaging studies.
    Schreiner F; Beuschlein F
    Best Pract Res Clin Endocrinol Metab; 2020 Mar; 34(2):101347. PubMed ID: 31662271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy.
    Clifton-Bligh RJ
    Rev Endocr Metab Disord; 2023 Feb; 24(1):49-56. PubMed ID: 36637675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.
    Lenders JW; Duh QY; Eisenhofer G; Gimenez-Roqueplo AP; Grebe SK; Murad MH; Naruse M; Pacak K; Young WF;
    J Clin Endocrinol Metab; 2014 Jun; 99(6):1915-42. PubMed ID: 24893135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pheochromocytoma and paraganglioma at a children's hospital in Argentina. A case series.
    Deregibus MI; Pompozzi LA; Sansó G
    Arch Argent Pediatr; 2024 Apr; 122(2):e202310099. PubMed ID: 37999372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pheochromocytoma and paraganglioma.
    Meyer-Rochow GY; Sidhu SB
    Cancer Treat Res; 2010; 153():135-62. PubMed ID: 19957224
    [No Abstract]   [Full Text] [Related]  

  • 20. Precision medicine in pheochromocytoma and paraganglioma: current and future concepts.
    Björklund P; Pacak K; Crona J
    J Intern Med; 2016 Dec; 280(6):559-573. PubMed ID: 27165774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.